Anlotinib in cancer therapy: mechanisms of action, clinical applications, and future perspectives.

IF 2.3 4区医学 Q3 ONCOLOGY

Cancer Chemotherapy and Pharmacology Pub Date : 2025-09-13 DOI:10.1007/s00280-025-04811-7

Jianhua Ding, Chai Hong Yeong, Lei Wang, Chunyan Shi, Long Li, Lijun Song, Wenxiu Ma, Peng Li

引用次数: 0

查看原文本刊更多论文

安洛替尼在癌症治疗中的作用机制、临床应用和未来展望。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Chemotherapy and Pharmacology 医学-药学

CiteScore

6.10

自引率

3.30%

发文量

116

审稿时长

2.5 months

期刊介绍： Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.